Highline Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.3K Buy
540
+68
+14% +$4.6K 0.01% 320
2026
Q2
$30.2K Buy
472
+429
+998% +$28.2K 0.01% 315
2026
Q1
$3.06K Sell
43
-36
-46% -$2.84K ﹤0.01% 888
2025
Q4
$6.48K Buy
79
+44
+126% +$3.43K ﹤0.01% 493
2025
Q3
$2.63K Hold
35
– – ﹤0.01% 799
2025
Q2
$2.59K Buy
35
+8
+30% +$557 ﹤0.01% 594
2025
Q1
$2.18K Buy
27
+7
+35% +$602 ﹤0.01% 612
2024
Q4
$1.56K Sell
20
-6
-23% -$510 ﹤0.01% 483
2024
Q3
$2.44K Buy
26
+6
+30% +$504 ﹤0.01% 435
2024
Q2
$1.56K Hold
20
– – ﹤0.01% 423
2024
Q1
$1.82K Hold
20
– – ﹤0.01% 338
2023
Q4
$1.55K Hold
20
– – ﹤0.01% 318
2023
Q3
$1.36K Hold
20
– – ﹤0.01% 293
2023
Q2
$1.62K Hold
20
– – ﹤0.01% 242
2023
Q1
$1.64K Buy
+20
New +$1.43K ﹤0.01% 242

Other funds holding GEHC

Highline Wealth Partners's GEHC Position: Q3 2026 in Review

Highline Wealth Partners increased its GE HealthCare (GEHC) stake by 14% in Q3 2026, buying an estimated $4.6K and bringing the position to 540 shares worth $35.3K. The position accounts for 0.01% of the portfolio, ranked #320.

Highline Wealth Partners first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. 609 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Highline Wealth Partners held 540 shares of GE HealthCare worth $35.3K as of Q3 2026.
  • Highline Wealth Partners bought 68 GE HealthCare shares in Q3 2026, an estimated $4.6K.
  • GE HealthCare made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #320 holding.
  • Highline Wealth Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • 609 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.